COMMUNIQUÉS West-GlobeNewswire

Chimerix to Address Congressional Subcommittee in Support of Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA)

05/06/2018 - 23:29

DURHAM, N.C., June 05, 2018 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address unmet medical needs, announced that President and Chief Executive Officer M. [...]

Teligent, Inc. Announces Closing Of $25 Million Secured Credit Facility

05/06/2018 - 22:45

BUENA, N.J., June 05, 2018 (GLOBE NEWSWIRE) -- TELIGENT, Inc. (NASDAQ:TLGT) Teligent, Inc. (“Teligent”) announced today that it has entered into a Credit Agreement with certain funds managed by Highbridge Capital [...]

Portola Pharmaceuticals to Present at Two Upcoming Investor Conferences

05/06/2018 - 22:30

SOUTH SAN FRANCISCO, Calif., June 05, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq:PTLA) today announced that the company will present at the following conferences in June: Goldman Sachs 39 th Annual [...]

MannKind Establishes Market Price Stock Purchase Plan

05/06/2018 - 22:30

WESTLAKE VILLAGE, Calif., June 05, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) has established a stock purchase plan that provides MannKind’s directors and executive officers with a way to purchase [...]

MacroGenics to Present at Jefferies Global Healthcare Conference

05/06/2018 - 22:30

ROCKVILLE, MD, June 05, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]

Madrigal Pharmaceuticals Announces Proposed Public Offering of Common Stock

05/06/2018 - 22:10

CONSHOHOCKEN, Pa., June 05, 2018 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq:MDGL), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutic [...]

GBT Announces New Employment Inducement Grants

05/06/2018 - 22:05

SOUTH SAN FRANCISCO, Calif., June 05, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT) today announced that, on June 1, 2018, the compensation committee of the Company’s board of directors [...]

Akcea Therapeutics Appoints Industry Leader Dr. Richard Moscicki to Board of Directors

05/06/2018 - 22:05

CAMBRIDGE, Mass., June 05, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ:AKCA), an affiliate of Ionis Pharmaceuticals, Inc., today announced the appointment of Richard (Rich) A. Moscicki, M.D., to the [...]

Aptose Biosciences Announces Results of Annual Meeting of Shareholders

05/06/2018 - 22:05

SAN DIEGO and TORONTO, June 05, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing highly differentiated therapeutics targeting the [...]

VBL Therapeutics Presents Positive Data on its MOSPD2 Platform Technology in Oncology and Inflammation at BIO 2018

05/06/2018 - 22:01

TEL AVIV, Israel, June 05, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (NASDAQ:VBLT) today presented data on its novel MOSPD2 program in oncology and inflammation at the 2018 BIO International Convention in Boston, [...]

Vericel Corporation Announces Closing of $74.8 Million Public Offering and Full Exercise of The Underwriters’ Option to Purchase Additional Shares

05/06/2018 - 22:01

CAMBRIDGE, Mass., June 05, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (Nasdaq:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced the closing of its [...]

Allscripts to present at Baird’s 2018 Global Consumer, Technology & Services Conference

05/06/2018 - 22:01

CHICAGO, June 05, 2018 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ:MDRX) today announced that certain members of its management team will present at Baird’s 2018 Global Consumer, Technology & Services Conference, to be [...]

argenx selected for BEL 20 Index

05/06/2018 - 22:00

June 5, 2018 Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment [...]

Syneos Health Consulting Releases 10th Annual Biopharmaceutical Dealmakers Survey – Predicts M&A Landscape to Continue Bull Run, While Buyers Begin to Become More Risk Averse

05/06/2018 - 22:00

BOSTON, June 05, 2018 (GLOBE NEWSWIRE) -- The tenth annual Dealmakers’ Intentions Study from Syneos Health Consulting, an industry-leading consulting firm specializing in the biopharmaceutical industry, concludes that [...]

Oncolytics Biotech® Closes USD $8.9 Million Public Offering of Common Shares

05/06/2018 - 18:49

CALGARY, Alberta and SAN DIEGO, June 05, 2018 (GLOBE NEWSWIRE) -- Oncolytics Biotech ® Inc. (TSX:ONC) (NASDAQ:ONCY), currently developing REOLYSIN ® (pelareorep), an intravenously delivered immuno-oncolytic virus [...]

Hospital Leaders to Explore ‘the Way Forward’ with Other Industries at Frontiers 2018

05/06/2018 - 18:00

Lumere to host event June 7–8 in Chicago CHICAGO, June 05, 2018 (GLOBE NEWSWIRE) -- As the healthcare industry shifts toward a focus on value-based care, hospitals and health systems must continue to innovate and [...]

Accelerate Diagnostics to Present at the William Blair 38th Annual Growth Stock Conference

05/06/2018 - 17:30

TUCSON, Ariz., June 05, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today that Lawrence Mehren, President and Chief Executive Officer is scheduled to speak at the William Blair 38 th Annual Growth [...]

Virbac : Declaration of the number of shares and voting rights as of May 2018, 31.

05/06/2018 - 17:29

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial [...]

Virbac : Déclaration d'actions et de droits de vote au 31 Mai 2018

05/06/2018 - 17:29

DECLARATION D'ACTIONS ET DE DROITS DE VOTE Informations relatives au nombre total de droits de vote et au nombre d'actions composant le capital (Article 223-16 du Règlement Général de l'Autorité des Marchés Financiers) [...]